Bank Of New York Mellon Corp Oyster Point Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.41 - $8.38 $47,777 - $90,788	10,834 New	10,834 $61,000
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $141,152 - $439,140	-39,209 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$8.58 - $17.65 $21,003 - $43,207	2,448 Added 6.66%	39,209 $456,000
Q4 2021 Feb 11, 2022	BUY	$10.17 - $18.96 $5,786 - $10,788	569 Added 1.57%	36,761 $672,000
Q3 2021 Nov 12, 2021	BUY	$11.67 - $18.07 $27,202 - $42,121	2,331 Added 6.88%	36,192 $428,000
Q2 2021 Aug 11, 2021	BUY	$16.25 - $21.51 $208,552 - $276,059	12,834 Added 61.04%	33,861 $582,000
Q1 2021 May 13, 2021	SELL	$17.92 - $25.86 $35,857 - $51,745	-2,001 Reduced 8.69%	21,027 $384,000
Q4 2020 Feb 09, 2021	BUY	$18.13 - $25.18 $23,061 - $32,028	1,272 Added 5.85%	23,028 $433,000
Q3 2020 Nov 12, 2020	BUY	$17.83 - $29.12 $48,782 - $79,672	2,736 Added 14.38%	21,756 $459,000
Q2 2020 Aug 12, 2020	SELL	$27.86 - $35.93 $29,308 - $37,798	-1,052 Reduced 5.24%	19,020 $549,000
Q1 2020 May 06, 2020	BUY	$23.65 - $40.96 $226,259 - $391,864	9,567 Added 91.07%	20,072 $702,000
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $142,342 - $274,705	10,505 New	10,505 $256,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.